1.89
1.89 (0%)
As of Dec 16, 2022
Kineta, Inc. [YMTX]
Source:
Company Overview
Kineta is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Kineta has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance.
Country | United States |
Headquarters | seattle, washington |
Phone Number | ( 206 ) 378-0400 |
Industry | manufacturing |
CEO | Shawn Iadonato |
Website | www.clinicaltrials.gov |